Pear Therapeutics

Jorge M. Gomez

Mr. Gomez has served as a member of Pear’s board of directors since August 2021 and is chair of the Audit Committee. He has been the executive vice president and chief financial officer of Dentsply Sirona, Inc (NASDAQ: XRAY), a manufacturer of professional dental products and technologies, since August 2019. Mr. Gomez previously served as chief financial officer of Cardinal Health, Inc (NYSE: CAH), a multinational healthcare services company, from January 2018 to August 2019. At Cardinal Health, he was responsible for financial activities across the enterprise, including financial strategy, capital deployment, treasury, investor relations, tax, accounting, and external reporting. From July 2015 to December 2017, he was chief financial officer of Cardinal Health’s medical segment and from February 2012 to June 2015, he was chief financial officer of Cardinal Health’s pharmaceutical segment. Prior to that, Mr. Gomez served as treasurer and corporate controller at Cardinal Health. Before joining Cardinal Health, Mr. Gomez held multiple executive and leadership roles at General Motors Company (NYSE: GM), including assignments in New York, Singapore, Belgium, and Brazil. He began his career with the Smurfit-Kappa Group plc (OTCMKTS: SMFTF) in the company’s finance development program. Currently, he also serves on the board of directors for Xylem, Inc (NYSE: XYL), a global water management company. Mr. Gomez earned a bachelor’s degree in electrical engineering from the National University of Colombia and a master’s degree in business administration from the University of Hartford.